LAVA Medtech Acquisition Corp.

Print
General Information
Business:
We intend to focus our investment efforts on industries that complement our management team’s background within healthcare and healthcare-related industries, primarily in the United States and Canada. Specifically, we intend to prioritize innovative, development- or early commercial-stage companies focused on clinically-impactful and high growth opportunities within medical devices, diagnostics, and digital health (comprehensively referred to as “MedTech”), which we believe are opportunity-rich, but somewhat overlooked areas relative to the strategies of most other blank check companies currently outstanding, particularly those focused on the healthcare sector.
(Note: LAVA Medtech Acquisition Corp. priced its SPAC IPO on Oct. 26, 2021, in sync with the terms in its prospectus: 10 million units at $10 each to raise $100 million.)
Industry: BLANK CHECKS
Employees: 0
Founded: 2021
Contact Information
Address 303 Wyman Street, Suite 300 Waltham, Massachusetts 02451
Phone Number 781-530-3868
Web Address
View Prospectus: LAVA Medtech Acquisition Corp.
Financial Information
Market Cap $125.0mil
Revenues $0 mil (last 12 months)
Net Income $0 mil (last 12 months)
IPO Profile
Symbol LVACU
Exchange NASDAQ
Shares (millions): 10.0
Price range $10.00 - $10.00
Est. $ Volume $100.0 mil
Manager / Joint Managers RBC Capital Markets
CO-Managers -
Expected To Trade: 10/27/2021
Status: Priced
Quiet Period Expiration Date:
Lock-Up Period Expiration Date:
SCOOP Rating
Rating Change